Human Kv3.4 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7140. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human Kv4.2/KChIP2.2 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7142. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human Kv4.3 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7144. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human Kv7.2/Kv7.3 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7147. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human TRPC1 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7163. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: Manual Patch Clamp
Human TRPC4 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7164. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: Manual Patch Clamp
Human TRPV6 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7169. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®
Human P2X2/P2X3 purinergic receptor -expressing, transiently transfected cells (HEK293). Cat#: CT7179. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human Kir6.2/SUR2A potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7183. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human Kir6.2/SUR2B potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7184. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human P2X1 Purinergic Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7186. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human P2X2 Purinergic Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7187. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: QPatch™ HT, FLIPR®
Human P2X3 Purinergic Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7188. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human P2X4 Purinergic Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7189. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Solid-phase extraction for increased productivity: LiChroPLATE® microtiter plates improve the sample throughput and speed of sample preparation. LiChroPLATE® enables solid-phase extraction to be carried out with considerable convenience and flexibility. From sample application with multi-channel pipettors to complete automation of the sample preparation process. Only in this way high sample throughputs can be achieved. LichroP…
Human P2X7 Purinergic Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7190. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: QPatch™ HT, FLIPR®
Human Kir6.2/SUR1 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7204. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human Kv1.6 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7220. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human Kv1.7 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7221. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human Kv2.1/Kv9.3 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7222. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human Kv4.1 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7224. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human Kv7.1/KCNE2 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7225. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human Kv1.5 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4137. Cryopreserved irradiated cells, 6x10E6 cells/vial. Platform validation:
Human phosphodiesterase 2A and a contitutively active Gs-coupled GPCR are stably expressed in HEK293-CNG (GPCR & Cyclic Nucleotide-Gated channel) cells. (HEK293-CNG-Gs). Cat#: CT81200-101. Cryopreserved cells, 2 vials: 2.5x10E6 cells/vial. Platform validation:
Endogenous phosphodiesterase 4 and a constitutively active Gs-coupled GPCR are stably expressed in GPCR-CNG (G protein-coupled receptor & Cyclic Nucleotide-Gated channel) cells. (HEK293-CNG-Gs). Cat#: CT81200-100. Cryopreserved cells, 2 vials: 2.5x10E6 cells/vial. Platform validation:
